Recent advances in vulvovaginal Candidiasis research: A narrative review DOI Creative Commons
Debasmita Dubey,

Gopal Krishna Purohit,

Shakti Rath

et al.

Novel Research in Microbiology Journal, Journal Year: 2023, Volume and Issue: 7(6), P. 2188 - 2198

Published: Nov. 1, 2023

Vulvovaginal Candidiasis (VVC) is a significant public health concern, and current article focuses primarily on understanding this infection's molecular processes. The hosts defence mechanisms their dysregulation, such as the innate immune response genetic susceptibility factors, play crucial role in determining to VVC. Candida-host interactions vaginal environment, including adhesion tissue invasion, have been extensively investigated, revealing intricate strategies employed by Candida spp. colonize persist human host. Moreover, virulence factors secreted spp., hydrolytic enzymes toxins, contribute damage modulation of response, aiding survival evasion host defences. formation biofilms complex structures, which are composed fungal cells encased an extracellular matrix, has emerged essential aspect VVC pathogenesis. Biofilms confer enhanced resistance antifungal agents, leading treatment challenges recurrent infections. Advancements various diagnostic techniques also played pivotal research. Molecular diagnostics, next-generation sequencing, proteomic approaches offer improved accuracy rapid identification enabling precise diagnosis personalized strategies. Such for developing novel therapeutic targets, disrupting mechanisms, inhibiting factor production, targeting biofilm formation. These advances hold promise more effective preventive strategies, interventions, tools. Overall, review aimed discuss recent research that provides valuable insights into infection driving vulvovaginal diagnosis, ultimately improving quality life women affected disease.

Language: Английский

First Report of the Emerging Pathogen Kodamaea ohmeri in Honduras DOI Creative Commons
Bryan Ortíz, Roque Sampedro López,

Carlos Aguirre Muñoz

et al.

Journal of Fungi, Journal Year: 2024, Volume and Issue: 10(3), P. 186 - 186

Published: Feb. 28, 2024

Kodamaea ohmeri is an environmental yeast considered a rare emerging pathogen. In clinical settings, the correct identification of this relevant because some isolates are associated with resistance to antifungals. There lack available data regarding geographical distribution, virulence, and drug profile K. ohmeri. To contribute knowledge yeast, study aimed describe in depth three fungemia Honduras. The was carried out by sequencing ribosomal ITS region. addition, susceptibility antifungals determined, properties virulence were evaluated (exoenzyme production, biofilm formation, cell adhesion, invasion). showed strong protease, phospholipase, hemolysin activity, addition being producers. Adherence invasion capacity evident HeLa Raw 264.7 lines, respectively. This expands understanding underlying biological traits ohmeri, it first report detection Honduras as cause human infection.

Language: Английский

Citations

2

Cyclic strain of poly (methyl methacrylate) surfaces triggered the pathogenicity of Candida albicans DOI Open Access
Carolina Montoya,

Julia Kurylec,

Alex Ossa

et al.

Acta Biomaterialia, Journal Year: 2023, Volume and Issue: 170, P. 415 - 426

Published: Aug. 24, 2023

Language: Английский

Citations

4

High-Throughput Screening of the Repurposing Hub Library to Identify Drugs with Novel Inhibitory Activity against Candida albicans and Candida auris Biofilms DOI Creative Commons

Olabayo H. Ajetunmobi,

Gina Wall,

Bruna Vidal Bonifácio

et al.

Journal of Fungi, Journal Year: 2023, Volume and Issue: 9(9), P. 879 - 879

Published: Aug. 27, 2023

Candidiasis is one of the most frequent nosocomial infections affecting an increasing number at-risk patients. Candida albicans remains causative agent candidiasis, but, in last decade, C. auris has emerged as a formidable multi-drug-resistant pathogen. Both species are fully capable forming biofilms, which contribute to resistance, urgency for new effective antifungal therapies. Repurposing existing drugs could significantly accelerate development novel therapies against candidiasis. Here, we have screened Hub library from Broad Institute, containing over 6000 compounds, search inhibitors and biofilm formation. The primary screen identified 57 initial hits 33 auris. Confirmatory concentration-dependent assays were used validate activity and, at same time, establish their anti-biofilm potency. Based on these results, ebselen, temsirolimus, compound BAY 11-7082 leading repositionable compounds. Subsequent experiments established spectrum yeasts filamentous fungi. In addition, vivo was examined murine models hematogenously disseminated infections. Although promising, further vitro studies needed confirm potential use therapy candidiasis possibly other fungal

Language: Английский

Citations

4

Biofilm Formation in Candida Species DOI

Mba Ifeanyi Elibe,

Nweze Emeka Innocent

Published: Jan. 1, 2024

Language: Английский

Citations

1

TheCandida albicansreference strain SC5314 contains a rare, dominant allele of the transcription factor Rob1 that modulates biofilm formation and oral commensalism DOI Creative Commons
Virginia E. Glazier,

Juraj Kramara,

Tomye Ollinger

et al.

bioRxiv (Cold Spring Harbor Laboratory), Journal Year: 2023, Volume and Issue: unknown

Published: June 17, 2023

Candida albicans is a diploid human fungal pathogen that displays significant genomic and phenotypic heterogeneity over range of virulence traits in the context variety environmental niches. Here, we show effects Rob1 on biofilm filamentation dependent both specific condition clinical strain C. . The reference SC5314 ROB1 heterozygote with two alleles differ by single nucleotide polymorphism at position 946 resulting serine or proline containing isoform. An analysis 224 sequenced genomes indicates only documented to date dominant allele contains 946. Remarkably, are functionally distinct rare 946S supports increased vitro formation vivo, suggesting it gain-of-function allele. amongst most highly filamentous invasive strains characterized date. Introduction into poorly filamenting isolate increases conversion an laboratory homozygote formation. In mouse model oropharyngeal infection, predominant 946P establishes commensal state while phenocopies parent invades mucosae. These observations provide explanation for phenotypes highlight role heterozygosity as driver heterogeneity. fungus colonizes oral cavity gastrointestinal tracts but also causes mucosal well disease. expression isolates heterogenous genetic basis this high interest. expresses robust relative many other isolates. derivatives heterozygous transcription factor contain SNP drives filamentation, formation, candidiasis. finding explain, part, outlier phenotype plays strain-to-strain variation pathogens.

Language: Английский

Citations

3

Biofilm formation by the fungus Phaeomoniella chlamydospora: a causal agent of esca disease of grapevine DOI Creative Commons
Zoltán Karácsony, Nikolett Molnár, Dóra Szabó

et al.

Mycological Progress, Journal Year: 2024, Volume and Issue: 23(1)

Published: June 20, 2024

Abstract The present study suggests that the Esca pathogenic fungus Phaeomoniella chlamydospora can form biofilm in vitro and possibly grapevine host tissues. This phenomenon was revealed by detailed examination of development three isolates fungus, showing dimorphic growth with formation yeast-like cells center, which were embedded a polysaccharide-rich extracellular matrix, filamentous at colony margins. colonies produced acetate, chemical proved to be an enhancer matrix production. dynamic correlated ability strains produce suggesting it acts as quorum sensing molecule process. P. also demonstrated tissues sole nutrient source, planta take part pathogenesis Esca. biofilms formed may contribute previously reported inhibition sap flow infected plants, while its sensing-mediated nature partly explain controversial literature data on occurrence pathogen symptom severity host.

Language: Английский

Citations

0

Synergistic antifungal effect of thiophene derivative as an inhibitor of fluconazole-resistant Candida spp. biofilms DOI

Adryelle Idalina da Silva Alves,

Bruna Rodrigues de Sousa,

Janderson Weydson Lopes Menezes da Silva

et al.

Brazilian Journal of Microbiology, Journal Year: 2024, Volume and Issue: unknown

Published: Aug. 7, 2024

Language: Английский

Citations

0

APMIS focus issue 2023—fungal infections: diagnostics and therapeutics DOI Open Access
Gordon Ramage, Åse Bengård Andersen

Apmis, Journal Year: 2023, Volume and Issue: 131(11), P. 559 - 560

Published: Sept. 15, 2023

Language: Английский

Citations

0

Recent advances in vulvovaginal Candidiasis research: A narrative review DOI Creative Commons
Debasmita Dubey,

Gopal Krishna Purohit,

Shakti Rath

et al.

Novel Research in Microbiology Journal, Journal Year: 2023, Volume and Issue: 7(6), P. 2188 - 2198

Published: Nov. 1, 2023

Vulvovaginal Candidiasis (VVC) is a significant public health concern, and current article focuses primarily on understanding this infection's molecular processes. The hosts defence mechanisms their dysregulation, such as the innate immune response genetic susceptibility factors, play crucial role in determining to VVC. Candida-host interactions vaginal environment, including adhesion tissue invasion, have been extensively investigated, revealing intricate strategies employed by Candida spp. colonize persist human host. Moreover, virulence factors secreted spp., hydrolytic enzymes toxins, contribute damage modulation of response, aiding survival evasion host defences. formation biofilms complex structures, which are composed fungal cells encased an extracellular matrix, has emerged essential aspect VVC pathogenesis. Biofilms confer enhanced resistance antifungal agents, leading treatment challenges recurrent infections. Advancements various diagnostic techniques also played pivotal research. Molecular diagnostics, next-generation sequencing, proteomic approaches offer improved accuracy rapid identification enabling precise diagnosis personalized strategies. Such for developing novel therapeutic targets, disrupting mechanisms, inhibiting factor production, targeting biofilm formation. These advances hold promise more effective preventive strategies, interventions, tools. Overall, review aimed discuss recent research that provides valuable insights into infection driving vulvovaginal diagnosis, ultimately improving quality life women affected disease.

Language: Английский

Citations

0